Plavix Generic Launch May Be Imminent
This article was originally published in The Pink Sheet Daily
Executive Summary
The potential of an at-risk launch of a generic Plavix led Medco to raise its earnings estimates, partially reflecting additional savings the Apotex generic could bring.
You may also be interested in...
Apotex Launches Generic Plavix
Bristol-Myers Squibb, Sanofi-Aventis may seek preliminary injunction against Apotex.
Apotex Launches Generic Plavix
Bristol-Myers Squibb, Sanofi-Aventis may seek preliminary injunction against Apotex.
Bristol/Sanofi’s Plavix Settlement Denied Antitrust Clearance
States attorneys general reject a proposed settlement one day after the companies announced they are facing a related DoJ criminal investigation.